Pages
Products
LacZ Adeno-associated virus(AAV Serotype 1)

LacZ Adeno-associated virus(AAV Serotype 1)

Cat.No. :  AAV00023Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 1 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Gene Informationn

Cat. No. AAV00023Z
Description LacZ Adeno-associated virus(AAV Serotype 1) which expresses β-galactosidase (LacZ) under CMV promoter. LacZ is frequently used as reporter gene. This is achieved by staining the tissues or cells with substrates like X-gal, which produces a blue color in the presence of beta-galactosidase.
Reporter LacZ
Serotype AAV Serotype 1
Product Type Adeno-associated virus
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Gene Name
Gene Symbol
Synonyms
Gene ID
Pathway
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

LacZ Adeno-associated virus (AAV) serotype 1 is a recombinant viral vector widely used in gene therapy research and molecular biology studies. AAV belongs to the Parvoviridae family and is a small, non-enveloped virus with a single-stranded DNA genome. Among the different AAV serotypes, serotype 1 (AAV1) is particularly noteworthy for its efficiency in transducing muscle cells, making it a popular choice for researchers focusing on muscle and cardiovascular diseases. LacZ is a gene encoding β-galactosidase, which is part of the lactose operon in Escherichia coli (E. coli), which also includes the lacY and lacA genes and regulatory elements. β-galactosidase mainly catalyzes the hydrolysis of lactose into glucose and galactose, which can be further used by bacteria as energy and carbon sources. In research, LacZ is widely used as a reporter gene, making it an important tool for studying gene expression and regulation. The activity of β-galactosidase can be easily monitored using substrates such as X-gal or ONPG, which produce a visible blue or yellow color, respectively, when cleaved by the enzyme. This visual output allows scientists to determine if the LacZ gene is being expressed, which in turn reflects the activity of the regulatory sequence being studied.

Increased soluble endoglin (sENG) is observed in human brain arteriovenous malformations (bAVM). Furthermore, simultaneous overexpression of sENG with vascular endothelial growth factor (VEGF)-A has been shown to induce dysplastic vessel formation in the mouse brain. In this study, researchers demonstrated that the presence of sENG and VEGF-A overexpression induced dysplastic blood vessel formation. They found that sENG increased VEGF-A, pro-inflammatory cytokines/inflammasome mediators (TNF-α, IL-6, NLRP3, ASC, Caspase-1 and IL-1β) and proteolytic enzyme (MMP-9) in BV2 microglia. sENG-treated BV2-conditioned medium (BV2-sENG-CM) significantly increased the levels of angiogenic factors (Notch-1 and TGFβ) and pERK1/2 in ECs but decreased the levels of the anti-angiogenic mediator IL-17RD. Finally, BV2-sENG-CM significantly increased EC migration and tube formation. Taken together, these studies indicated that sENG stimulates microglia to express angiogenic/inflammatory molecules that may be involved in EC dysfunction.

Because enhanced circulating sENG was detected in patients with bAVM, researchers systematically injected recombinant human sENG into mice with focal cerebral VEGF-A overexpression via intracerebral injection of AAV1-VEGF-A (Figure 1A). In mice treated with sENG and overexpressing VEGF-A, blue latex-cast brains clearly showed dysplastic and enlarged vasculatures. The dysplastic vessels formed around the AAV1-VEGF-A-injected site (ipsilateral) (Figure 1B), and the volume of dysplastic vessels was significantly increased compared to normal vessels in the other hemisphere without AAV1-VEGF-A injection (contralateral) (Figure 1B,C). No dysplastic vessels were found in the brains of mice with only VEGF-A overexpression, i.e., mice that were not injected with sENG or treated with sENG injected with control AAV1-LacZ (Figure 1C). By immunostaining with a CD31 antibody, the researchers confirmed the presence of significantly dilated blood vessels in the brains of mice with VEGF-A overexpression and sENG administration (Figure 1D). These data suggest that the combination of sENG and VEGF-A overexpression results in vascular malformations.

Soluble ENG/VEGF-A induces the formation of dysplastic vessels in the mouse brain.Figure 1. Soluble ENG/VEGF-A induces the formation of dysplastic vessels in the mouse brain. (Park E S, et al., 2022)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High Safety

Compared to other viral vectors we’ve tested, the LacZ Adeno-associated virus(AAV Serotype 1) stands out due to its high safety profile and low immunogenicity.

United States

03/16/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction